Trihexyphenidyl Hydrochloride Tablet
Product Images NDC 70518-1612

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Trihexyphenidyl Hydrochloride (NDC 70518-1612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Trihexyphenidyl HCl 2mg 70518 1612 00)

Trihexyphenidyl HCI is a prescription medication manufactured by Actavis, and distributed by RemedyRepack Inc. The drug is indicated for the treatment of Parkinson's disease and drug-induced extrapyramidal symptoms related to antipsychotic therapy. It should be kept out of the reach of children and stored at room temperature. Additional instructions should be included in the package insert. The expiration date and lot number should be found on the packaging.*

FDA Label Image

Mm2 (Trihexyphenidyl HCl 2mg 70518 1612 01)

Trihexyphenidyl HCI is a prescription medicine with the NDC number 70518-1612-01. The medication is manufactured by Actavis in Sunrise, FL 33325, and its source NDC is 00591-5335-01. The Lot number and expiry date information are missing. The medication should be kept away from children and stored at 20-26°C (63-77°F); excursions permitted to 15-30°C (59-86°F). Specific directions for use are available in the package insert. It was repackaged by RemedyRepack Inc. in Indiana, PA 15701.*

FDA Label Image

Mm3 (Trihexyphenidyl HCl 2mg 70518 1612 02)

Trihexyphenidyl HCI is a prescription medication that requires Medical Doctor dispensing. The NDC number, lot number, and manufacturing details are provided. The medication should be stored within the temperature range of 20-26°C (63-77°F), with excursions allowed to 15-30°C (59-86°F), and away from the reach of children. The directions for use are provided in the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana.*

FDA Label Image

7066154a-figure-01 (Image 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.